What types of professional services does CDER prioritize for contract awards?

CDER frequently seeks subject matter expertise in biostatistics, clinical pharmacology, medical writing, and regulatory policy development to support the drug approval lifecycle.

How does CDER handle IT procurement for its regulatory review systems?

CDER invests heavily in data management, cloud computing, and cybersecurity solutions that enable the secure processing and analysis of massive datasets submitted by pharmaceutical sponsors.

Are there specific certifications that help vendors win CDER contracts?

While not a formal requirement, vendors holding GSA Professional Services Schedule contracts or those with deep experience in GxP compliance and FDA regulatory standards often have a competitive advantage.

FOOD AND DRUG ADMINISTRATION · Contracting Office

FDA CENTER FOR DRUG EVALUATION AND RESEARCH

41 solicitations and awards tracked for this contracting office.

Contracting office41 solicitationsUnder FOOD AND DRUG ADMINISTRATION

Solicitations

Federal records indexed

Source

Federal

Federal procurement data

Sub-Agency

FOOD AND

FOOD AND DRUG ADMINISTRATION

Agency

DEPARTMENT

DEPARTMENT OF HEALTH AND HUMAN SERVICES

About

Acquisition authority and contracting profile of FDA CENTER FOR DRUG EVALUATION AND RESEARCH.

The FDA Center for Drug Evaluation and Research (CDER) procures specialized scientific, technical, and regulatory support to facilitate the review and approval of human drugs. Vendors compete for contracts involving clinical trial data analysis, pharmacovigilance, drug safety monitoring, and the development of complex regulatory information technology systems.

Hierarchy: FOOD AND DRUG ADMINISTRATION · DEPARTMENT OF HEALTH AND HUMAN SERVICES.

Contracting officers at this office issue solicitations under the Federal Acquisition Regulation (FAR). Vendors must be registered in the federal procurement system with a valid CAGE code to receive awards.

Opportunity activity heatmap (2024-present)

Monthly posted opportunity volume from 2024 onward. Darker = more indexed records.

Count-basedPeak month: 42024-2026

2024

2025

2026

This view uses monthly opportunity counts from the public dataset. Monthly obligation dollars are not available on these pages.

FewerMore

FDA CENTER FOR DRUG EVALUATION AND RESEARCH contracting FAQ

Common questions about FDA CENTER FOR DRUG EVALUATION AND RESEARCH, the parent hierarchy, and how vendors should track this contracting office.